Cite
HARVARD Citation
Zhu, L. et al. (2021). Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease. ACR open rheumatology. 3 (1), pp. 3-7. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, L. et al. (2021). Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease. ACR open rheumatology. 3 (1), pp. 3-7. [Online].